TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Cessation
Intimation of Cessation of Directors of the Company01-04-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Cessation
Intimation of Cessation of Directors of the CompanyTORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Retirement
Intimation of Cessation of Directors of CompanyTORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of Cessation of Directors of the CompanyTORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Intimation of the Closure of Trading WindowTORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificatesTorrent Pharma shares hit 52-week high on successful inspection by USFDA
The share price gained 80 percent in last one-year.TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation u/r 30 of SEBI (LODR) Regulations, 2015TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share CertificateTORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share CertificatesTORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015